Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic characterization of purple acid phosphatases provides targets for improving phosphorus use efficiency in cotton.

Functional & integrative genomics·2026
Same author

Multifunctional bioactivity of Echinops niveus: Antimicrobial, antioxidant, and cytotoxic evaluation.

Folia microbiologica·2026
Same author

Selective Anticancer Effects of Portulaca grandiflora via Apoptosis and NF-κB Pathway Modulation in MDA-MB-231 Cells.

Applied biochemistry and biotechnology·2026
Same author

VerbaFake, EchoFake, and PixelFake: lightweight architectures with advanced augmentation for unimodal deepfake detection.

Scientific reports·2026
Same author

Retraction notice to "Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications" [Biomedicine & Pharmacotherapy 162 (2023) 114687].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Terminating the Revolving Cycle of Silence: A Co-Production Study of a Media Campaign Intervention to Encourage Males Affected by Intimate Partner Violence Help-Seeking in Nigeria.

American journal of men's health·2026

Related Experiment Video

Updated: Jun 11, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

An overview about hepatitis C: a devastating virus.

Nazish Bostan1, Tariq Mahmood

  • 1Department of Biological Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan.

Critical Reviews in Microbiology
|March 30, 2010
PubMed
Summary
This summary is machine-generated.

Hepatitis C (HCV) is a global health threat affecting 200 million people. Its high mutation rate and diversity, including genotypes and quasispecies, contribute to serious liver disease complications.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Experiment Videos

Last Updated: Jun 11, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C (HCV) affects approximately 200 million individuals globally.
  • Persistent HCV infection can lead to severe liver conditions such as cirrhosis, hepatocellular carcinoma, and end-stage liver disease.
  • HCV exhibits high viral RNA replication rates and a significant mutational capacity, facilitating immune evasion.

Purpose of the Study:

  • To summarize the global impact and characteristics of Hepatitis C virus.
  • To highlight the viral diversity, including genotypes and quasispecies, and their implications.
  • To underscore the public health burden and clinical significance of HCV infection.

Main Methods:

  • Literature review and synthesis of existing data on HCV prevalence, pathology, and viral characteristics.
  • Analysis of HCV genetic diversity, including major genotypes and subtypes.
  • Examination of geographical distribution patterns and viral population dynamics.

Main Results:

  • HCV is a prevalent global pathogen with significant morbidity and mortality.
  • HCV demonstrates high replication rates and a rapid mutation rate, enabling immune system escape.
  • Six major genotypes (1-6) and over 50 subtypes exist, each with distinct geographical distributions and evolving populations.

Conclusions:

  • Hepatitis C virus poses a substantial worldwide health challenge due to its prevalence and severe long-term complications.
  • Understanding HCV's genetic diversity and evolutionary dynamics is crucial for developing effective control and treatment strategies.
  • The geographical distribution and ongoing viral drift of HCV necessitate continued global surveillance and research efforts.